• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮合并症的不断演变的概念。

The evolving concept of SLE comorbidities.

作者信息

González Luis Alonso, Alarcón Graciela S

机构信息

a Division of Rheumatology, Department of Internal Medicine, School of Medicine , Universidad de Antioquia , Medellín , Colombia.

b Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine , The University of Alabama at Birmingham , Birmingham , AL , USA.

出版信息

Expert Rev Clin Immunol. 2017 Aug;13(8):753-768. doi: 10.1080/1744666X.2017.1327353. Epub 2017 May 22.

DOI:10.1080/1744666X.2017.1327353
PMID:28471690
Abstract

The survival of SLE patients has improved significantly over the past few decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and osteoporosis, among other comorbidities. The aim of this review was to assess the incidence and prevalence of comorbidities in these patients as well as their prevention and treatment focusing in CVD, malignancies and osteoporosis. Areas covered: We focused on CVD, malignancies and osteoporosis as SLE comorbidities. A literature search (PubMed database) was performed using the words 'comorbidities', 'cardiovascular disease', 'osteoporosis', 'malignancy', 'cancer' and 'lupus' between January 1976 and December 2016. No language restrictions were placed. More than 100 full-length articles were reviewed. Expert commentary: The therapeutic approach in SLE should aim not only at achieving disease remission but also at treating all conditions affecting the patients and, consequently, their outcomes. These patients should be treated as coronary artery disease (CAD) equivalent with rigorous modifiable CV risk factors management in addition to the optimal treatment of their lupus. Furthermore, modifiable osteoporosis traditional risk factors and SLE-related risk factors should be modified to ameliorate bone loss and fracture risk. Cancer preventive measures (smoking cessation and screening programs for cervical cancer) constitute also essential components of the management of these patients.

摘要

在过去几十年里,系统性红斑狼疮(SLE)患者的生存率有了显著提高,但这也使他们患心血管疾病(CVD)、恶性肿瘤和骨质疏松症等其他合并症的风险增加。本综述的目的是评估这些患者合并症的发病率和患病率,以及针对CVD、恶性肿瘤和骨质疏松症的预防和治疗。涵盖领域:我们重点关注CVD、恶性肿瘤和骨质疏松症这几种SLE合并症。在1976年1月至2016年12月期间,使用“合并症”“心血管疾病”“骨质疏松症”“恶性肿瘤”“癌症”和“狼疮”等关键词在PubMed数据库中进行了文献检索。未设语言限制。共查阅了100多篇全文文章。专家评论:SLE的治疗方法不仅应旨在实现疾病缓解,还应治疗影响患者的所有病症,从而改善其预后。除了对狼疮进行最佳治疗外,这些患者应被视为等同于冠状动脉疾病(CAD),对可改变的心血管危险因素进行严格管理。此外,应改变可改变的骨质疏松传统危险因素和与SLE相关的危险因素,以减轻骨质流失和骨折风险。癌症预防措施(戒烟和宫颈癌筛查项目)也是这些患者管理的重要组成部分。

相似文献

1
The evolving concept of SLE comorbidities.系统性红斑狼疮合并症的不断演变的概念。
Expert Rev Clin Immunol. 2017 Aug;13(8):753-768. doi: 10.1080/1744666X.2017.1327353. Epub 2017 May 22.
2
The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.系统性红斑狼疮患者动脉粥样硬化性心血管疾病的流行病学:系统评价。
Semin Arthritis Rheum. 2013 Aug;43(1):77-95. doi: 10.1016/j.semarthrit.2012.12.002. Epub 2013 Feb 17.
3
Bone health and systemic lupus erythematosus.骨骼健康与系统性红斑狼疮
Curr Rheumatol Rep. 2005 Dec;7(6):482-9. doi: 10.1007/s11926-005-0056-1.
4
Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.中国系统性红斑狼疮患者中传统和狼疮特异性心血管疾病危险因素的流行情况及其相关性。
J Eur Acad Dermatol Venereol. 2012 Jan;26(1):95-101. doi: 10.1111/j.1468-3083.2011.04211.x. Epub 2011 Aug 18.
5
Comorbidities of pediatric systemic lupus erythematosus: A 6-year nationwide population-based study.儿童系统性红斑狼疮的合并症:一项基于全国人口的6年研究。
J Microbiol Immunol Infect. 2016 Apr;49(2):257-63. doi: 10.1016/j.jmii.2014.05.001. Epub 2014 Jul 24.
6
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.系统性红斑狼疮患者心血管疾病的传统及狼疮特异性危险因素患病率:一项病例对照研究。
Arthritis Rheum. 2006 Dec 15;55(6):892-9. doi: 10.1002/art.22343.
7
Osteoporosis in systemic lupus erythematosus mechanisms.系统性红斑狼疮中的骨质疏松症机制。
Rheum Dis Clin North Am. 2005 May;31(2):363-85, viii. doi: 10.1016/j.rdc.2005.01.004.
8
Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.波多黎各系统性红斑狼疮及相关合并症的患病率。
J Clin Rheumatol. 2007 Aug;13(4):202-4. doi: 10.1097/RHU.0b013e318124a8af.
9
Why are kids with lupus at an increased risk of cardiovascular disease?为什么狼疮患儿患心血管疾病的风险会增加?
Pediatr Nephrol. 2016 Jun;31(6):861-83. doi: 10.1007/s00467-015-3202-7. Epub 2015 Sep 23.
10
Systemic lupus erythematosus and malignancies: a review article.系统性红斑狼疮与恶性肿瘤:一篇综述文章
Rheum Dis Clin North Am. 2014 Aug;40(3):497-506, viii. doi: 10.1016/j.rdc.2014.04.005. Epub 2014 Jun 3.

引用本文的文献

1
Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort.在一个大型多中心系统性红斑狼疮队列中,共病簇及其与索引疾病的严重程度和结局的关系。
Lupus Sci Med. 2025 Jul 1;12(2):e001633. doi: 10.1136/lupus-2025-001633.
2
Disease association study of Autoimmune and autoinflammatory diseases by integrating multi-modal data and hierarchical ontologies.通过整合多模态数据和层次本体对自身免疫性疾病和自身炎症性疾病进行疾病关联研究。
Front Immunol. 2025 Jun 4;16:1575490. doi: 10.3389/fimmu.2025.1575490. eCollection 2025.
3
Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study.
系统性红斑狼疮肺部表现的综合风险评估:一项基于韩国大规模人群的纵向研究。
RMD Open. 2025 Feb 23;11(1):e005267. doi: 10.1136/rmdopen-2024-005267.
4
Exploring the quality of life and comorbidity impact among patients with systemic lupus erythematosus in Saudi Arabia.探讨沙特阿拉伯系统性红斑狼疮患者的生活质量和合并症影响。
Saudi Med J. 2024 Oct;45(10):1071-1079. doi: 10.15537/smj.2024.45.10.20240432.
5
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage.真实世界中系统性红斑狼疮患者的治疗模式:与合并症和损伤的关联。
Lupus Sci Med. 2024 Sep 24;11(2):e001266. doi: 10.1136/lupus-2024-001266.
6
Risk factors for the development of cervical cancer: analysis of the evidence.宫颈癌发生的危险因素:证据分析
Front Oncol. 2024 May 23;14:1378549. doi: 10.3389/fonc.2024.1378549. eCollection 2024.
7
The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.TRIM21/Ro52在系统性红斑狼疮、原发性干燥综合征、癌症及癌症代谢中的相互关联作用。
Cancer Cell Int. 2023 Nov 22;23(1):289. doi: 10.1186/s12935-023-03143-x.
8
Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis.英国成年系统性红斑狼疮患者的疾病严重程度、病情发作及治疗模式:一项真实世界观察性回顾性队列分析
Rheumatol Adv Pract. 2021 Aug 27;5(3):rkab061. doi: 10.1093/rap/rkab061. eCollection 2021.
9
High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete.系统性红斑狼疮患者的高合并症负担:来自克里特岛社区狼疮登记处的数据。
J Clin Med. 2021 Mar 2;10(5):998. doi: 10.3390/jcm10050998.
10
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials.阿尼鲁单抗治疗活动期系统性红斑狼疮患者的安全性特征:II 期和 III 期临床试验的综合分析。
Lupus Sci Med. 2021 Feb;8(1). doi: 10.1136/lupus-2020-000464.